COMP <GO>
CLPT vs OFIX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
ClearPoint Neuro Inc. (NASDAQ) VS. Orthofix Medical Inc. (NASDAQ) • 15-METRIC TALLY: CLPT 2
— OFIX 8
■ METRIC PARITY
LAST: $9.95 (-6.75%) • MKT CAP: $342.0M
options-implied-move
—
LAST: $8.75 (-3.53%) • MKT CAP: $369.4M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLPT VS. OFIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLPT | OFIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.40% | 68.80% | -7.40 | OFIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -12.20% | -22.80 | OFIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.13% | 7.99% | -15.12 | OFIX | /fcf-yield <GO> |
| Operating Margin | -60.00% | -9.90% | -50.10 | OFIX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -11.20% | -48.80 | OFIX | /net-margins <GO> |
| Revenue Growth (YoY) | 17.80% | 2.90% | +14.90 | CLPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 1.02 | -0.82 | OFIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | OFIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 44.8 | +4.10 | CLPT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $342.0M | $369.4M | -$27.4M | OFIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLPT REV | OFIX REV | CLPT GROSS % | OFIX GROSS % | CLPT FCF | OFIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $37.0M | $822.3M | 61.4% | 68.8% | -$24.4M | $33.3M |
| FY 2024 | $31.4M | $799.5M | 60.9% | 68.3% | -$9.2M | $25.8M |
| FY 2023 | $24.0M | $746.6M | — | — | -$13.7M | -$45.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLPT // BETA —
OFIX // BETA —